Bumetanide 1mg tablets are out of stock until mid-August 2025.

The supply disruption is caused by a combination of manufacturing issues and a resulting increase in demand to other suppliers.

Bumetanide 1mg/5ml oral solution and bumetanide 5mg tablets remain available, however cannot support any increase in demand.

Furosemide 20mg and 40mg tablets remain available and can support increased demand.

This National Patient Safety Alert provides further background, clinical information and actions for providers.